Details of the Drug Excipient
General Information of Drug Inactive Ingredient (DIG) (ID: E00037)
| DIG Name |
Palmitic acid
|
||||
|---|---|---|---|---|---|
| Synonyms |
palmitic acid; Hexadecanoic acid; 57-10-3; Cetylic acid; palmitate; n-Hexadecanoic acid; Hexadecylic acid; Hydrofol; n-Hexadecoic acid; 1-Pentadecanecarboxylic acid; Palmitinic acid; Pentadecanecarboxylic acid; C16 fatty acid; hexaectylic acid; 1-Hexyldecanoic Acid; Industrene 4516; Emersol 140; Emersol 143; Hystrene 8016; Hystrene 9016; hexadecoic acid; Palmitic acid, pure; Palmitinsaeure; Palmitic acid 95%; Palmitic acid (natural); Fatty acids, C14-18; Prifac 2960; FEMA No. 2832; Pristerene 4934; Edenor C16; Kortacid 1698; Lunac P 95KC; C16:0; Loxiol EP 278; Lunac P 95; Lunac P 98; Hydrofol Acid 1690; HSDB 5001; AI3-01594; C16H32O2; NSC 5030; MFCD00002747; UNII-2V16EO95H1; Palmitic acid (NF); Glycon P-45; CHEBI:15756; NSC5030; Hexadecanoic acid (9CI); Palmitic acid (7CI,8CI); CHEMBL82293; 67701-02-4; CH3-[CH2]14-COOH; 2V16EO95H1; n-hexadecoate; LMFA01010001; PA 900; FA 1695; 1-hexyldecanoate; Palmitic acid, 98%; NCGC00164358-01; DSSTox_CID_1602; pentadecanecarboxylate; DSSTox_RID_76229; DSSTox_GSID_21602; PLM; palmitic-acid; palmic acid; Hexadecanoate (n-C16:0); Hexadecanoic-16,16,16-d3acid; CAS-57-10-3; CCRIS 5443; SR-01000944716; EINECS 200-312-9; Palmitic acid [USAN:NF]; BRN 0607489; palmitoate; Hexadecoate; Palmitinate; palmitoic acid; Aethalic acid; Hexadecanoic acid Palmitic acid; (C14-C18)Alkylcarboxylic acid; 2hmb; 2hnx; (C14-C18) Alkylcarboxylic acid; Fatty acid pathway; palmitic acid group; Palmitic acid_jeyam; EINECS 266-926-4; Palmitic Acid, FCC; Kortacid 1695; Palmitic acid_RaGuSa; Univol U332; Prifrac 2960; Hexadecanoic acid anion; 3v2q; ACMC-1ASQF; SDA 17-005-00; Palmitic acid, >=99%; bmse000590; Epitope ID:141181; EC 200-312-9; Hexadecanoic-9,9-d2 acid; SCHEMBL6177; 4-02-00-01157 (Beilstein Handbook Reference); FAT; WLN: QV15; P5585_SIGMA; Palmitic acid-[9,10-3H]; GTPL1055; QSPL 166; CCCCCCCCCCCCCCCC([O])=O; DTXSID2021602; HEXADECANOIC-12-D1 ACID; 1b56; HMS3649N08; Palmitic acid, analytical standard; Palmitic acid, BioXtra, >=99%; HEXADECANOIC-3,3-D2 ACID; HEXADECANOIC-4,4-D2 ACID; Palmitic acid, Grade II, ~95%; HY-N0830; NSC-5030; Palmitic acid, natural, 98%, FG; ZINC6072466; Tox21_112105; Tox21_201671; Tox21_302966; ANW-13574; BBL011563; BDBM50152850; s3794; SBB017229; STL146733; Palmitic acid, >=95%, FCC, FG; AKOS005720983; HEXADECANOIC-13,13-D2 ACID; Light end (C14-C18) saturated fatty acid fraction from tallow fatty acids; Tox21_112105_1; CCG-267027; CR-0047; DB03796; FA 16:0; MCULE-1361949901; Palmitic acid, for synthesis, 98.0%; NCGC00164358-02; NCGC00164358-03; NCGC00256424-01; NCGC00259220-01; AK-48351; I728; Palmitic acid, purum, >=98.0% (GC); ST023798; SY006518; CS-0009861; FT-0626965; FT-0772579; N2456; P0002; P1145; Palmitic acid, SAJ first grade, >=95.0%; Hexadecanoic-11,11,12,12-d4acid (9CI); Palmitic acid-15,15,16,16,16-[d5]; A14813; C00249; D05341; Hexadecanoic acid 10 microg/mL in Acetonitrile; Palmitic acid, Vetec(TM) reagent grade, 98%; Palmitic acid, >=98% palmitic acid basis (GC); HEXADECANOIC ACID-13C16 (ALGAL SOURCE) (; Q209727; SR-01000944716-1; SR-01000944716-2; BA71C79B-C9B1-451A-A5BE-B480B5CC7D0C; F0001-1488; Z955123552; Palmitic acid, certified reference material, TraceCERT(R); UNII-13FB83DEYU component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-44NH37HHP9 component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-5U9XZ261ER component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-7N137Q0QYJ component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-96GS7P39SN component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-B6G0Y5Z616 component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-D1CZ545P7Z component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-HBA528N3PW component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-J505W0PXX8 component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-MO7HV04S9Y component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-ODL221H4AM component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-Q8Y7S3B85M component IPCSVZSSVZVIGE-UHFFFAOYSA-N; UNII-V1PY73ZXPE component IPCSVZSSVZVIGE-UHFFFAOYSA-N; Palmitic acid, European Pharmacopoeia (EP) Reference Standard; UNII-79P21R4317 component IPCSVZSSVZVIGE-UHFFFAOYSA-N; Palmitic acid, United States Pharmacopeia (USP) Reference Standard; Palmitic acid, Pharmaceutical Secondary Standard; Certified Reference Material; 272442-14-5; 285979-77-3; 30719-28-9; 358730-99-1; 62690-28-2; 75736-57-1; 81462-28-4; 83293-32-7; HEXADECANOIC-9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,16-D17 ACID; Sodium Palmitate, Palmitic acid sodium salt, Sodium hexadecanoate, Sodium pentadecanecarboxylate, HSDB 759
|
||||
| DIG Function |
Emulsifying agent; Penetration agent; lubricant
|
||||
| Formula |
C16H32O2
|
||||
| Canonical SMILES |
CCCCCCCCCCCCCCCC(=O)O
|
||||
| InChI |
1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18)
|
||||
| InChIKey |
IPCSVZSSVZVIGE-UHFFFAOYSA-N
|
||||
| Physicochemical Properties | Molecular Weight | 256.42 | Topological Polar Surface Area | 37.3 | |
| XlogP | 6.4 | Complexity | 178 | ||
| Heavy Atom Count | 18 | Rotatable Bond Count | 14 | ||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 2 | ||